Sen. Ron Wyden (D-Ore.), chairman of the Senate Finance Committee, announced a Dec. 5 hearing on prescription drug shortages that will include testimony from two witnesses who have published research on the 340B program.
Senate Committee Doubles Down on PBM Bill with 340B Spread Pricing Language